The Patient Advocate Foundation Launches Fund for MCC Patients to Help Cover Travel Costs Associated With Treatment
July 9, 2019
The fund supports patients who have been diagnosed with the rare form of skin cancer known as Merkel Cell Carcinoma (MCC). Once approved, the financial fund provides one-time assistance of $450 to cover transportation-related expenses connected to treatment appointments. Eligible patients include those who are undergoing active treatment, have received treatment within the previous 6 months, or will be receiving treatment in the next 60 days. Each patient must meet household income guidelines and provide diagnosis documentation in order to finalize the application. Review the program disclaimer for this fund.
For more information click here.